Following approval, the medicine will be available in store with no age or point-of-sale restrictions, and consumers will not have to present their identification for purchasing the medicine.
Teva Global Women’s Health senior vice president & general manager Jill DeSimone said Plan B One-Step allows women to get what they need with one dose, without waiting 12 hours to take a second pill to complete the regimen.
"At Teva we are committed to ensuring information, educational tools and healthcare professional support are made available to all those who need it, right at the time that they need it," DeSimone added.
The company said that the alarming rate of unplanned pregnancy stands at 49% of all pregnancies in the US, which underlines easy and convenient access to emergency contraception.
Teva Women’s Health operates as a US subsidiary of Teva Pharmaceutical Industries headquartered in Israel, which manufactures various women’s healthcare products, including oral contraceptives, intrauterine contraception and hormone therapy treatments.